Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Friday Links

Posted on December 20, 2024December 19, 2024 by John C. Goodman
  • More US pharmacies closed than opened in 2018-2021.
  • The most promising solution to antibiotic resistance comes from Komodo dragons – they almost never get infected. 
  • Why the Social Security Fairness Act is anything but fair. 
  • Can the murder of UHC CEO Bryan Thompson be blamed on Obamacare?
  • A recent Federal Trade Commission report detailed 300 instances in which large PBMs favored a medication that cost at least $500 more per claim than a safe, cheaper alternative.
  • The case for more clinical trials.
+

Wednesday Links

Posted on December 18, 2024December 18, 2024 by John C. Goodman
  • “The study found that cold killed 17.4 people for every person killed by heat.”
  • Trump: Ignore a lot of RFK Jr.’s past statements.
  • The prices paid in 2019 by Blue Cross Blue Shield health plans in hospital outpatient departments were double those paid in physician offices for biologics, chemotherapies, and other infused cancer drugs,
  • Novartis announced that its new gene therapy cancer treatment (Kymriah) will cost $475,000 for the one-time infusion. There is no charge if the treatment doesn’t work.
  • The case for vaccines.
  • The evolution of managed care: form doctor/hospital run HMOs to AI.
+

Sunday Links

Posted on December 15, 2024December 15, 2024 by John C. Goodman
  • Cato: “We estimate that the [Inflation Reduction Act] will cost more than $1 trillion over the next 10 years and between $2 trillion and $4 trillion by 2050.”
  • Despite a bumpy start, hospital price transparency requirements are having an effect: a movement toward price convergence.
  • How health insurers use AI to deny health care claims.
  • MAGA opportunity: McKinsey estimates the global market for “consumer wellness” products at $1.8 trillion—making it roughly twice the size of the pharmaceutical industry
+

Friday Links

Posted on December 13, 2024December 13, 2024 by John C. Goodman
  • How Medicare Advantage works: “The plans look for unhealthy people who likely have been poorly served by the fee-for-service system.  These people both have big payment multipliers attached to them and offer lots of opportunity for improving care and lowering costs.”
  • How to reform the NIH.
  • Covid lockdowns had almost no affect on the top students, but was devastating for those at the bottom.
  • Cato’s suggestions for DOGE.
  • The money donated to restore Notre Dame could instead have saved 47,500 lives from death by malaria – and maybe twice that number.
+
  • Previous
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 253
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 45 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom